This announcement is a separate document:
ペルセウスプロテオミクス：PPMX-T003：真性多血症（PV）の第I相臨床試験の終了に関するお知らせ
Perseus Proteomics: Announcements of individual stocks: Notice regarding the completion of Phase I clinical trial for genuine polycythemia vera (PV) - PPMX-T003
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.